— Know what they know.
Not Investment Advice
Asset Manager ← All Institutions

GSK plc

Q2 2026 · Filed 2026-08-13
Market Value
$496M
+6.3%
Holdings
12
-1
New Purchases
0
Added To
0
Closed
0
Reduced
0
Top 10 Concentration
98.3%
Turnover
0.0%

Top Buys (by % of Portfolio)

SymbolCur %Prior %Chg %Value
CRSP 35.40% 32.82% +2.58% $176M
VIR 17.56% 16.41% +1.15% $87M
CYTK 5.84% 4.81% +1.04% $29M
IDYA 10.01% 9.52% +0.50% $50M
NKTX 1.80% 1.42% +0.37% $9M
RGNX 0.66% 0.49% +0.17% $3M

Top Sells (by % of Portfolio)

SymbolCur %Prior %Chg %Value
LYEL 4.28% 6.50% -2.22% $21M
FULC 1.32% 2.93% -1.62% $7M
CVRX 1.04% 2.04% -1.00% $5M
SPRO 4.09% 4.61% -0.51% $20M
BNTX 16.69% 16.94% -0.25% $83M
BCYC 1.31% 1.52% -0.21% $6M

Sector Allocation Over Time

Market Cap Concentration

TierHoldingsValueWeight
Large Cap 1 $83M 16.7%
Mid Cap 3 $254M 51.3%
Small Cap 2 $90M 18.2%
Micro Cap 6 $69M 13.8%

Portfolio Analytics

Avg Market Cap
$3.7B
Median Market Cap
$333M
Avg P/E
8.5
Median P/E
8.5
Avg Dividend Yield
—%
Avg Beta
1.13
# Stocks
12
# ETFs / Funds
0

Top Holdings (12 total)

# Symbol % Port Shares Value Avg Price Q/Q Value Chg Share Chg Chg % Status
1 CRSP 35.40% 3,220,627 $176M $54.54 $22M — —
2 VIR 17.56% 8,550,954 $87M $10.19 $11M — —
3 BNTX 16.69% 889,824 $83M $93.05 $4M — —
4 IDYA 10.01% 1,333,333 $50M $37.27 $5M — —
5 CYTK 5.84% 340,434 $29M $85.19 $7M — —
6 LYEL 4.28% 1,512,659 $21M $14.05 -$9M — —
7 SPRO 4.09% 9,190,606 $20M $2.21 -$1M — —
8 NKTX 1.80% 3,150,732 $9M $2.83 $2M — —
9 FULC 1.32% 1,785,714 $7M $3.66 -$7M — —
10 BCYC 1.31% 1,529,561 $6M $4.24 -$612K — —
11 CVRX 1.04% 1,007,583 $5M $5.14 -$4M — —
12 RGNX 0.66% 271,456 $3M $11.98 $977K — —
View SEC EDGAR Filings for GSK plc →

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms